.Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01A_AnteriorPituitaryLobeHormonesAndAnalogues.H01AC08_Somatrogon.Somatrogon .Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01A_AnteriorPituitaryLobeHormonesAndAnalogues.H01AC08_Somatrogon.Somatrogon| name: | Somatrogon | |
| ATC code: | H01AC08 | route: | subcutaneous |
| compartments: | 2 | |
| dosage: | 0.66 | mg |
| volume of distribution: | 0.14 | L |
| clearance: | 0.0058 | L/hr/kg |
| other parameters in model implementation | ||
Somatrogon is a long-acting recombinant human growth hormone used for the treatment of pediatric patients with growth hormone deficiency (GHD). It is approved for medical use in several countries for once-weekly administration to enhance growth in children with inadequate endogenous growth hormone secretion.
Population pharmacokinetic model in pediatric patients with growth hormone deficiency receiving subcutaneous once-weekly somatrogon. Parameter values reported as typical for children (aged 3–12 years, both sexes, with GHD).